ABVX — Abivax SA Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Abivax SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | FAS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.4 | -60.7 | -148 | -176 | — |
| Depreciation | |||||
| Non-Cash Items | 0.635 | 8.32 | 28.6 | 19.6 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.99 | -2 | 21.3 | 1.43 | -156 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -45.6 | -53.9 | -97.1 | -154 | -156 |
| Capital Expenditures | -0.047 | -0.323 | -0.265 | -0.643 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.53 | -11.7 | -7.83 | 16.4 | -8.2 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.57 | -12 | -8.1 | 15.8 | -8.2 |
| Financing Cash Flow Items | — | -4.45 | -34.6 | -11 | 547 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 78.5 | 32.2 | 335 | 28.2 | 547 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 31.4 | -33.8 | 225 | -108 | 373 |